Elanco Animal Health (NYSE:ELAN – Free Report) had its target price cut by UBS Group from $18.00 to $17.00 in a research note released on Wednesday morning,Benzinga reports. They currently have a buy ...

Elanco Animal Health (NYSE:ELAN – Free Report) had its target price trimmed by Barclays from $20.00 to $19.00 in a research report released on Wednesday morning,Benzinga reports. The firm currently ...

Zoetis also has an H5N1 vaccine, for which it received a conditional license in 2016 and a contract award for the USDA’s ...

Elanco has struck an agreement to distribute a vaccine that may protect cattle for up to 12 months against bird flu ...

In a big win for House Speaker Mike Johnson, House Republicans got their budget plan through the chamber on a 217-215 vote.

Elanco Animal Health Incorporated has entered into an agreement with South Dakota-based Medgene to leverage the company's ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based Medgene to leverage the company’s innovative vaccine platform technology.

Morgan Stanley lowered the firm’s price target on Elanco (ELAN) to $13 from $14 and keeps an Equal Weight rating on the shares. Q4 EPS of 14c ...

Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health’s Fourth Quarter 2024 Earnings Conference ...

Stifel analyst Jonathan Block lowered the firm’s price target on Elanco (ELAN) to $15 from $16 and keeps a Buy rating on the shares. While the ...

Elanco Animal Health announced the establishment of an agreement with Medgene, a South Dakota-based biotechnology company, to utilize its advanced vaccine platform technology (baculovirus derived ...

Elanco's Q4 revenue reached $1.02 billion, topping estimates, but EPS missed forecasts. 2025 guidance lags consensus as currency headwinds pose a $110 million challenge.